ArticleEuropean heart journal. Case reports2026
Successful pulsed field ablation for refractory premature ventricular contractions using a novel dual-energy focal catheter: a case report.
Article in European heart journal. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Radiofrequency ablation (RFA) is an established therapy for symptomatic premature ventricular contractions (PVCs), but arrhythmias from deep intramural substrates may remain refractory. Pulsed field ablation (PFA) is a nonthermal modality with myocardial selectivity, and dual-energy focal catheters allow delivery of both RFA and PFA using a single device. We report successful PFA for RFA-refractory PVCs using this technology. Case Summary: An 81-year-old man with ischaemic cardiomyopathy and symptomatic monomorphic PVCs was referred after failed prior RFA of both right ventricular outflow tract (RVOT) and left ventricular outflow tract (LVOT). During repeat ablation, activation mapping identified earliest activation at the septal RVOT and anterior LVOT. Using a dual-energy focal catheter, sequential RFA and PFA were delivered at both sites. In the RVOT, PFA caused only transient suppression with recurrence of PVCs. In the LVOT, the first PFA application failed to eliminate PVCs, whereas additional applications resulted in immediate and sustained suppression. No complications occurred, and the patient remained free of PVCs during follow-up. Discussion: This case demonstrates the feasibility of dual-energy focal catheter-based PFA for ventricular arrhythmias refractory to RFA. The elimination of PVCs after repeated PFA suggests that multiple PFA applications may enhance lesion formation in deep intramural substrates. However, this observation should be interpreted cautiously because histological confirmation was unavailable and alternative explanations, including cumulative energy exposure and autonomic variability during conscious sedation, cannot be excluded. Further studies are required to define optimal energy strategy, lesion characteristics, and long-term outcomes of dual-energy ablation for ventricular arrhythmias.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.